FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Spencer

Research Profile

Disorders

Chemicals & Drugs

Procedures

Double-Blind Method

Concepts & Ideas

Co-author Network

Publications

TOP 3
Joseph Biederman; Stephen V Faraone; Marykate Martelon; Thomas J Spencer; K Yvonne Woodworth; Janet R Wozniak
Personal and familial correlates of bipolar (BP)-I disorder in children with a diagnosis of BP-I disorder with a positive child behavior checklist (CBCL)-severe dysregulation profile: a controlled study.
Lenard A Adler; Jennifer V Davidow; Paul Hammerness; Christina Minerly; Jeffrey H Newcorn; David M Shaw; David J Sitt; Thomas J Spencer; Stephen V Faraone
Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents.
Thomas J Spencer; Jessica Martin; Tara Mirto; Ali A Bonab; Allison Clarke; Darin D Dougherty; Alan J Fischman
Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: a positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Spencer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joseph Biederman; Stephen V Faraone; Marykate Martelon; Thomas J Spencer; K Yvonne Woodworth; Janet R Wozniak
Personal and familial correlates of bipolar (BP)-I disorder in children with a diagnosis of BP-I disorder with a positive child behavior checklist (CBCL)-severe dysregulation profile: a controlled study.
Journal of affective disorders 2013;147(1-3):164-70.
2012: Lenard A Adler; Jennifer V Davidow; Paul Hammerness; Christina Minerly; Jeffrey H Newcorn; David M Shaw; David J Sitt; Thomas J Spencer; Stephen V Faraone
Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents.
Journal of child and adolescent psychopharmacology 2012;22(3):238-44.
2012: Thomas J Spencer; Jessica Martin; Tara Mirto; Ali A Bonab; Allison Clarke; Darin D Dougherty; Alan J Fischman
Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: a positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane.
The Journal of clinical psychiatry 2012;73(3):346-52.
2012: Joseph Biederman; Laran L Hyder; Katherine B O'Connor; Carter Petty; Thomas J Spencer; Craig Bh Surman; Stephen V Faraone
Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study.
Neuropsychiatric disease and treatment 2012;8():267-76.
2012: Thomas J Spencer; Tara McDonnell Moorehead; Jessica M Martin; Tara Mirto; Holly Batchelder; Joseph Biederman; Allison Clarke; Stephen V Faraone
Importance of pharmacokinetic profile and timing of coadministration of short- and long-acting formulations of methylphenidate on patterns of subjective responses and abuse potential.
Postgraduate medicine 2012;124(1):166-73.
2011: Lenard A Adler; Jennifer V Davidow; Stephen J Glatt; Melinda Morrill; Jeffrey H Newcorn; David M Shaw; David J Sitt; Thomas J Spencer; Stephen V Faraone
Reliability and validity of the Time-Sensitive ADHD Symptom Scale in adults.
Comprehensive psychiatry 2011;52(6):769-73.
2011: Thomas J Spencer; Craig B H Surman; Janet Wozniak; Holly Batchelder; Allison Clarke; Stephen V Faraone; Carter Petty; Joseph Biederman
Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study.
Postgraduate medicine 2011;123(5):50-9.
2011: Lenard A Adler; Jennifer V Davidow; AnaChristina E Minerly; Jeffrey H Newcorn; David M Shaw; David J Sitt; Thomas J Spencer; Stephen V Faraone
Preliminary reliability and validity of a new time-sensitive ADHD symptom scale in adolescents with ADHD.
Postgraduate medicine 2011;123(5):7-13.
2011: Joseph Biederman; Ronna Fried; Eric Mick; Thomas J Spencer; Nicole Wilner; Stephen V Faraone
Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2011;21(7):508-15.
2011: Thomas J Spencer; Eric Mick; Craig B H Surman; Paul Hammerness; Robert Doyle; Aleardi Megan; Meghan Kotarski; Courtney G Williams; Joseph Biederman
A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate.
Journal of attention disorders 2011;15(4):286-94.
2011: Paula T Trzepacz; Michael M Witte; Shuyu Zhang; Mark E Bangs; Thomas J Spencer; Durisala Desaiah
Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial.
Current medical research and opinion 2011;27 Suppl 2():45-52.
2010: Thomas J Spencer; Bertha K Madras; Ali A Bonab; Darin D Dougherty; Allison Clarke; Tara Mirto; Jessica Martin; Alan J Fischman
A positron emission tomography study examining the dopaminergic activity of armodafinil in adults using [¹¹C]altropane and [¹¹C]raclopride.
Biological psychiatry 2010;68(10):964-70.
2010: Thomas J Spencer; Lenard A Adler; Keith E Saylor; Thomas E Brown; James A Holdnack; Kory J Schuh; Paula T Trzepacz; Douglas Kelsey
Validation of the adult ADHD investigator symptom rating scale (AISRS).
Journal of attention disorders 2010;14(1):57-68.
2010: Thomas J Spencer; Ali A Bonab; Darin D Dougherty; Jessica Martin; Tara McDonnell; Alan J Fischman
A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults.
International journal of molecular medicine 2010;25(2):261-5.
2009: Timothy E Wilens; Joseph Biederman; Stephen V Faraone; Marykate Martelon; Diana Westerberg; Thomas J Spencer
Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD.
The Journal of clinical psychiatry 2009;70(11):1557-62.
2009: Thomas J Spencer; Michael Greenbaum; Lawrence D Ginsberg; William Rory Murphy
Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Journal of child and adolescent psychopharmacology 2009;19(5):501-10.
2008: Thomas J Spencer; Jeanne M Landgraf; Lenard A Adler; Richard H Weisler; Colleen S Anderson; Sharon H Youcha
Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study.
The Journal of clinical psychiatry 2008;69(11):1766-75.
2008: Thomas J Spencer
Adult ADHD: diversion and misuse of medications.
CNS spectrums 2008;13(10 Suppl 15):9-13.
2008: Thomas J Spencer; Lenard A Adler; Richard H Weisler; Sharon H Youcha
Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study.
The Journal of clinical psychiatry 2008;69(9):1437-48.
2008: Thomas J Spencer
Neurobiology and genetics of ADHD in adults.
CNS spectrums 2008;13(9 Suppl 13):5-7.
2008: Thomas J Spencer
The epidemiology of adult ADHD.
CNS spectrums 2008;13(8 Suppl 12):6-8.
2008: Thomas J Spencer
Treatment of adult ADHD and comorbid depression.
CNS spectrums 2008;13(5 Suppl 8):14-6.
2008: Lenard A Adler; Stephen Faraone; Thomas J Spencer; David Michelson; Frederick W Reimherr; Stephen J Glatt; Barrie K Marchant; Joseph Biederman
The reliability and validity of self- and investigator ratings of ADHD in adults.
Journal of attention disorders 2008;11(6):711-9.
2008: Lenard A Adler; Thomas J Spencer; Louise R Levine; Janet L Ramsey; Roy Tamura; Douglas Kelsey; Susan G Ball; Albert J Allen; Joseph Biederman
Functional outcomes in the treatment of adults with ADHD.
Journal of attention disorders 2008;11(6):720-7.
2008: Joseph Biederman; Sarah W Ball; Michael C Monuteaux; Eric Mick; Thomas J Spencer; Michelle McCreary; Michelle Cote; Stephen Faraone
New insights into the comorbidity between ADHD and major depression in adolescent and young adult females.
Journal of the American Academy of Child and Adolescent Psychiatry 2008;47(4):426-34.
2008: Gladys A Bush; Thomas J Spencer; Jennifer Holmes; Lisa M Shin; Eve M Valera; Larry J Seidman; Nikos Makris; Craig Surman; Aleardi Megan; Eric Mick; Joseph Biederman
Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Archives of general psychiatry 2008;65(1):102-14.
2008: Thomas J Spencer; Floyd R Sallee; Donald L Gilbert; David W Dunn; James T McCracken; Barbara J Coffey; Cathy L Budman; Randall K Ricardi; Henrietta L Leonard; Albert J Allen; Denái R Milton; Peter Feldman; Douglas Kelsey; Daniel A Geller; Steven L Linder; Donald W Lewis; Paul Winner; Roger Kurlan; Mark Mintz
Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
Journal of attention disorders 2008;11(4):470-81.
2007: Thomas J Spencer; Joseph Biederman; Bertha K Madras; Darin D Dougherty; Ali A Bonab; Eli Livni; Peter C Meltzer; Jessica Martin; Scott Rauch; Alan J Fischman
Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane.
Biological psychiatry 2007;62(9):1059-61.
2007: Thomas J Spencer; Christopher J Kratochvil; R Bart Sangal; Keith E Saylor; Charles E Bailey; David W Dunn; Daniel A Geller; Charles D Casat; Robert S Lipetz; Rakesh Jain; Jeffrey H Newcorn; Dustin D Ruff; Peter Feldman; Amanda J Furr; Albert J Allen
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
Journal of child and adolescent psychopharmacology 2007;17(5):689-700.
2007: Michael C Monuteaux; Thomas J Spencer; Stephen Faraone; Angela M Wilson; Joseph Biederman
A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder.
The Journal of clinical psychiatry 2007;68(7):1094-101.
2007: Thomas J Spencer; Joseph Biederman; Eric Mick
Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.
Journal of pediatric psychology 2007;32(6):631-42.
2007: Thomas J Spencer; Lenard A Adler; James J McGough; Rafael Muniz; Hai Jiang; Linda Pestreich
Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.
Biological psychiatry 2007;61(12):1380-7.
2007: Thomas J Spencer
Pharmacology of adult ADHD with stimulants.
CNS spectrums 2007;12(4 Suppl 6):8-11.
2007: Jan K Buitelaar; David Michelson; Marina Danckaerts; Christopher Gillberg; Thomas J Spencer; Alessandro Zuddas; Douglas E Faries; Shuyu Zhang; Joseph Biederman
A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.
Biological psychiatry 2007;61(5):694-9.
2007: Joseph Biederman; Eric Mick; Craig Surman; Robert Doyle; Paul Hammerness; Evan Michel; Jessica Martin; Thomas J Spencer
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.
BMC psychiatry 2007;7():49.
2007: Joseph Biederman; Ronna Fried; Michael C Monuteaux; Bryan Reimer; Joseph F Coughlin; Craig Surman; Aleardi Megan; Meghan Dougherty; Steven Schoenfeld; Thomas J Spencer; Stephen Faraone
A laboratory driving simulation for assessment of driving behavior in adults with ADHD: a controlled study.
Annals of general psychiatry 2007;6():4.
2007: Thomas J Spencer; Joseph Biederman; Eric Mick
Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.
Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association 2007;7(1 Suppl):73-81.
2007: Joseph Biederman; Thomas J Spencer; Jeffrey H Newcorn; Haitao Gao; Denái R Milton; Peter Feldman; Michael M Witte
Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.
Psychopharmacology 2007;190(1):31-41.
2006: Bertha K Madras; Zhihua Xie; Zhicheng Lin; Amy Jassen; Helen Panas; Laurie Lynch; Ryan Johnson; Eli Livni; Thomas J Spencer; Ali A Bonab; Gregory M Miller; Alan J Fischman
Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.
The Journal of pharmacology and experimental therapeutics 2006;319(2):561-9.
2006: Joseph Biederman; Thomas J Spencer; Timothy E Wilens; Jefferson B Prince; Stephen Faraone
Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(10):1147-50.
2006: Timothy E Wilens; Jefferson B Prince; Thomas J Spencer; Joseph Biederman
Stimulants and sudden death: what is a physician to do?
Pediatrics 2006;118(3):1215-9.
2006: Richard H Weisler; Joseph Biederman; Thomas J Spencer; Timothy E Wilens; Stephen Faraone; Allan K Chrisman; Stephanie C Read; Simon J Tulloch
Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.
CNS spectrums 2006;11(8):625-39.
2006: Carl M Anderson; Luis C Maas; Blaise deB Frederick; Jacob Bendor; Thomas J Spencer; Eli Livni; Scott E Lukas; Alan J Fischman; Bertha K Madras; Perry F Renshaw; Marc J Kaufman
Cerebellar vermis involvement in cocaine-related behaviors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(6):1318-26.
2006: Timothy E Wilens; Randall M Zusman; Paul Hammerness; Amy Podolski; Julia Whitley; Thomas J Spencer; Martin Gignac; Joseph Biederman
An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.
The Journal of clinical psychiatry 2006;67(5):696-702.
2006: Joseph Biederman; Stephen Faraone; Thomas J Spencer; Eric Mick; Michael C Monuteaux; Aleardi Megan
Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community.
The Journal of clinical psychiatry 2006;67(4):524-40.
2006: Thomas J Spencer; Howard B Abikoff; Daniel F Connor; Joseph Biederman; Steven R Pliszka; Samuel Boellner; Stephanie C Read; Raymond Pratt
Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Clinical therapeutics 2006;28(3):402-18.
2006: Thomas J Spencer; Stephen Faraone; David Michelson; Lenard A Adler; Frederick W Reimherr; Stephen J Glatt; Joseph Biederman
Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity.
The Journal of clinical psychiatry 2006;67(3):415-20.
2006: Thomas J Spencer; Joseph Biederman; Patrick E Ciccone; Bertha K Madras; Darin D Dougherty; Ali A Bonab; Eli Livni; Dolly A Parasrampuria; Alan J Fischman
PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.
The American journal of psychiatry 2006;163(3):387-95.
2006: Joseph Biederman; Sharon B Wigal; Thomas J Spencer; James J McGough; David A Mays
A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Clinical therapeutics 2006;28(2):280-93.
2006: Thomas J Spencer; Timothy E Wilens; Joseph Biederman; Richard H Weisler; Stephanie C Read; Raymond Pratt
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Clinical therapeutics 2006;28(2):266-79.
2006: Robert L Doyle; Jean Frazier; Thomas J Spencer; Daniel Geller; Joseph Biederman; Timothy Wilens
Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series.
Journal of attention disorders 2006;9(3):543-9.
2006: Stephen Faraone; Joseph Biederman; Thomas J Spencer; Aleardi Megan
Comparing the efficacy of medications for ADHD using meta-analysis.
MedGenMed : Medscape general medicine 2006;8(4):4.
2006: Thomas J Spencer
ADHD and comorbidity in childhood.
The Journal of clinical psychiatry 2006;67 Suppl 8():27-31.
2006: Joseph Biederman; Amy F T Arnsten; Stephen Faraone; Alysa E Doyle; Thomas J Spencer; Timothy E Wilens; Margaret D Weiss; Steven A Safren; Larry Culpepper
New developments in the treatment of ADHD.
The Journal of clinical psychiatry 2006;67(1):148-59.
2005: Albert J Allen; Roger Kurlan; D L Gilbert; Barbara J Coffey; S L Linder; D W Lewis; Paul Winner; David W Dunn; Leon S Dure; Floyd R Sallee; Denái R Milton; M I Mintz; Randall K Ricardi; Gerald Erenberg; L L Layton; Peter Feldman; Douglas Kelsey; Thomas J Spencer
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
Neurology 2005;65(12):1941-9.
2005: Timothy E Wilens; James Waxmonsky; Megan Scott; Allison Swezey; Anne Kwon; Thomas J Spencer; Joseph Biederman
An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder.
Journal of child and adolescent psychopharmacology 2005;15(6):947-55.
2005: Joseph Biederman; Thomas J Spencer; Timothy E Wilens; Richard H Weisler; Stephanie C Read; Simon J Tulloch
Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD.
CNS spectrums 2005;10(12 Suppl 20):16-25.
2005: Timothy E Wilens; Thomas J Spencer; Joseph Biederman
Short- and long-term cardiovascular effects of mixed amphetamine salts extended-release in adolescents with ADHD.
CNS spectrums 2005;10(10 Suppl 15):22-30.
2005: Thomas J Spencer; Joseph Biederman; Timothy E Wilens
Efficacy and tolerability of long-term, open-label, mixed amphetamine salts extended release in adolescents with ADHD.
CNS spectrums 2005;10(10 Suppl 15):14-21.
2005: Thomas J Spencer
Mixed amphetamine salts extended release for the treatment of ADHD in adolescents: current evidence.
CNS spectrums 2005;10(10 Suppl 15):5.
2005: Robert L Findling; Joseph Biederman; Timothy E Wilens; Thomas J Spencer; James J McGough; Frank A Lopez; Simon J Tulloch
Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children.
The Journal of pediatrics 2005;147(3):348-54.
2005: Sharon B Wigal; James J McGough; James T McCracken; Joseph Biederman; Thomas J Spencer; Kelly Posner; Timothy Wigal; Scott H Kollins; Tanya M Clark; David A Mays; Yuxin Zhang; Simon J Tulloch
A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
Journal of attention disorders 2005;9(1):275-89.
2005: Thomas J Spencer; Jeffrey H Newcorn; Christopher J Kratochvil; Dustin D Ruff; David Michelson; Joseph Biederman
Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder.
Pediatrics 2005;116(1):e74-80.
2005: Thomas J Spencer; Joseph Biederman; Bertha K Madras; Stephen Faraone; Darin D Dougherty; Ali A Bonab; Alan J Fischman
In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter.
Biological psychiatry 2005;57(11):1293-300.
2005: Lenard A Adler; Thomas J Spencer; Denái R Milton; Rodney J Moore; David Michelson
Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis.
The Journal of clinical psychiatry 2005;66(3):294-9.
2005: Jeffrey H Newcorn; Thomas J Spencer; Joseph Biederman; Denái R Milton; David Michelson
Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2005;44(3):240-8.
2005: Timothy E Wilens; Paul Hammerness; Joseph Biederman; Anne Kwon; Thomas J Spencer; Sarah Clark; Megan Scott; Amy Podolski; Jeffrey W Ditterline; Matthew C Morris; Hadley Moore
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
The Journal of clinical psychiatry 2005;66(2):253-9.
2004: David Michelson; Jan K Buitelaar; Marina Danckaerts; Christopher Gillberg; Thomas J Spencer; Alessandro Zuddas; Douglas E Faries; Shuyu Zhang; Joseph Biederman
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(7):896-904.
2004: Stephen Faraone; Thomas J Spencer; C Brendan Montano; Joseph Biederman
Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care.
Archives of internal medicine 2004;164(11):1221-6.
2004: Thomas J Spencer
Adult attention-deficit/hyperactivity disorder.
The Psychiatric clinics of North America 2004;27(2):XI-XII.
2004: Thomas J Spencer
ADHD treatment across the life cycle.
The Journal of clinical psychiatry 2004;65 Suppl 3():22-6.
2003: James J McGough; Joseph Biederman; Laurence L Greenhill; James T McCracken; Thomas J Spencer; Kelly Posner; Sharon B Wigal; Jeffrey Gornbein; Simon J Tulloch; James M Swanson
Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.
Journal of the American Academy of Child and Adolescent Psychiatry 2003;42(6):684-91.
2003: James T McCracken; Joseph Biederman; Laurence L Greenhill; James M Swanson; James J McGough; Thomas J Spencer; Kelly Posner; Sharon B Wigal; Caroly Pataki; Yuxin Zhang; Simon J Tulloch
Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.
Journal of the American Academy of Child and Adolescent Psychiatry 2003;42(6):673-83.
2003: Timothy E Wilens; Joseph Biederman; Peter Forkner; Jeff Ditterline; Mathew Morris; Hadley Moore; Maribel Galdo; Thomas J Spencer; Janet Wozniak
Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder.
Journal of child and adolescent psychopharmacology 2003;13(4):495-505.
2003: Timothy E Wilens; Joseph Biederman; Anne Kwon; Rhea Chase; Laura Greenberg; Eric Mick; Thomas J Spencer
A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors.
Journal of child and adolescent psychopharmacology 2003;13(2):143-52.
2002: Christopher J Kratochvil; John H Heiligenstein; Ralf Dittmann; Thomas J Spencer; Joseph Biederman; Joachim F Wernicke; Jeffrey H Newcorn; Charles D Casat; Denái Milton; David Michelson
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(7):776-84.
2002: Timothy E Wilens; Thomas J Spencer; Joseph Biederman
A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder.
Journal of attention disorders 2002;5(4):189-202.
2002: Timothy E Wilens; Joseph Biederman; Sarah Brown; Sarah Tanguay; Michael C Monuteaux; Christie Blake; Thomas J Spencer
Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(3):262-8.
2002: Timothy E Wilens; Joseph Biederman; Sarah Brown; Michael C Monuteaux; Jefferson Prince; Thomas J Spencer
Patterns of psychopathology and dysfunction in clinically referred preschoolers.
Journal of developmental and behavioral pediatrics : JDBP 2002;23(1 Suppl):S31-6.
2002: Keith E Saylor; Curtis M Buermeyer; Thomas J Spencer; Russell A Barkley
Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication.
The Journal of clinical psychiatry 2002;63 Suppl 12():23-8.
2002: Thomas J Spencer; Joseph Biederman; Timothy E Wilens; Stephen Faraone
Novel treatments for attention-deficit/hyperactivity disorder in children.
The Journal of clinical psychiatry 2002;63 Suppl 12():16-22.
2002: Thomas J Spencer; Joseph Biederman; Timothy E Wilens; Stephen Faraone
Overview and neurobiology of attention-deficit/hyperactivity disorder.
The Journal of clinical psychiatry 2002;63 Suppl 12():3-9.
2002: Timothy E Wilens; Joseph Biederman; Elizabeth Bredin; Amy L Hahesy; Ana Abrantes; Deborah Neft; Rachael Millstein; Thomas J Spencer
A family study of the high-risk children of opioid- and alcohol-dependent parents.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2002;11(1):41-51.
2002: Timothy E Wilens; Joseph Biederman; Thomas J Spencer
Attention deficit/hyperactivity disorder across the lifespan.
Annual review of medicine 2002;53():113-31.
2002: Daniel A Geller; Joseph Biederman; Stephen Faraone; Kathleen Cradock; Lisa Hagermoser; Noreen Zaman; Jean A Frazier; Barbara J Coffey; Thomas J Spencer
Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact?
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(1):52-8.
2001: Thomas J Spencer; Joseph Biederman; Janet Wozniak; Stephen Faraone; Timothy E Wilens; Eric Mick
Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders.
Biological psychiatry 2001;49(12):1062-70.
2001: Thomas J Spencer; Joseph Biederman; Stephen Faraone; Eric Mick; Barbara J Coffey; Daniel Geller; J Kagan; Sarah Kate Bearman; Timothy Wilens
Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD.
The American journal of psychiatry 2001;158(4):611-7.
2001: Timothy E Wilens; Thomas J Spencer; Joseph Biederman; K Girard; Robert Doyle; Jefferson Prince; DA Polisner; R Solhkhah; S Comeau; Michael C Monuteaux; A Parekh
A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.
The American journal of psychiatry 2001;158(2):282-8.
2000: Stephen Faraone; Joseph Biederman; Thomas J Spencer; Timothy E Wilens
The drug-placebo response curve: a new method for assessing drug effects in clinical trials.
Journal of clinical psychopharmacology 2000;20(6):673-9.
2000: Joseph Biederman; Thomas J Spencer
Genetics of childhood disorders: XIX. ADHD, Part 3: Is ADHD a noradrenergic disorder?
Journal of the American Academy of Child and Adolescent Psychiatry 2000;39(10):1330-3.
2000: Barbara J Coffey; Joseph Biederman; Daniel A Geller; Thomas J Spencer; G S Kim; CA Bellordre; J A Frazier; Kathleen Cradock; Mariola Magovcevic
Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2000;39(5):556-61.
2000: Timothy E Wilens; Joseph Biederman; J Wong; Thomas J Spencer; Jefferson B Prince
Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series.
Journal of child and adolescent psychopharmacology 2000;10(3):217-22.
2000: Jeff Q Bostic; Joseph Biederman; Thomas J Spencer; Timothy E Wilens; Jefferson B Prince; Michael C Monuteaux; M Sienna; DA Polisner; M Hatch
Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
Journal of child and adolescent psychopharmacology 2000;10(3):205-16.
2000: Jefferson B Prince; Timothy E Wilens; Joseph Biederman; Thomas J Spencer; Rachael Millstein; DA Polisner; Jeff Q Bostic
A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder.
Journal of child and adolescent psychopharmacology 2000;10(3):193-204.
2000: Timothy E Wilens; Joseph Biederman; Sharon Milberger; Amy L Hahesy; S Goldman; Janet Wozniak; Thomas J Spencer
Is bipolar disorder a risk for cigarette smoking in ADHD youth?
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2000;9(3):187-95.
1999: Darin D Dougherty; Ali A Bonab; Thomas J Spencer; S L Rauch; Bertha K Madras; Alan J Fischman
Dopamine transporter density in patients with attention deficit hyperactivity disorder.
Lancet 1999;354(9196):2132-3.
1999: Timothy E Wilens; Joseph Biederman; Thomas J Spencer; Jeff Q Bostic; Jefferson Prince; Michael C Monuteaux; J Soriano; C Fine; Allyson M Abrams; M Rater; DA Polisner
A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder.
The American journal of psychiatry 1999;156(12):1931-7.
1999: Joseph Biederman; Stephen Faraone; Eric Mick; S Williamson; Timothy E Wilens; Thomas J Spencer; W Weber; JG Jetton; I Kraus; J Pert; Barry Zallen
Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(8):966-75.
1999: Jean A Frazier; M C Meyer; Joseph Biederman; Janet Wozniak; Timothy E Wilens; Thomas J Spencer; G S Kim; S Shapiro
Risperidone treatment for juvenile bipolar disorder: a retrospective chart review.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(8):960-5.
1999: Timothy E Wilens; Joseph Biederman; Rachael Millstein; Janet Wozniak; Amy L Hahesy; Thomas J Spencer
Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(6):680-5.
1999: Timothy E Wilens; Joseph Biederman; Thomas J Spencer; J Frazier; Jefferson Prince; Jeff Q Bostic; M Rater; J Soriano; M Hatch; M Sienna; Rachael Millstein; A Abrantes
Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder.
Journal of clinical psychopharmacology 1999;19(3):257-64.
1999: Timothy E Wilens; Thomas J Spencer; J M Swanson; Daniel F Connor; Dennis P Cantwell
Combining methylphenidate and clonidine: a clinically sound medication option.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(5):614-9; discussion 619-22.
1999: Timothy E Wilens; Joseph Biederman; John S March; Robert Wolkow; C S Fine; Rachael Millstein; Stephen Faraone; D Geller; Thomas J Spencer
Absence of cardiovascular adverse effects of sertraline in children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(5):573-7.
1999: L G Cohen; J Biederman; Timothy E Wilens; Thomas J Spencer; Eric Mick; Stephen Faraone; Jefferson Prince; JG Flood
Desipramine clearance in children and adolescents: absence of effect of development and gender.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(1):79-85.
1999: Janet Wozniak; M H Crawford; Joseph Biederman; Stephen Faraone; Thomas J Spencer; A Taylor; H K Blier
Antecedents and complications of trauma in boys with ADHD: findings from a longitudinal study.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(1):48-55.
1998: Timothy E Wilens; D Wyatt; Thomas J Spencer
Disentangling disinhibition.
Journal of the American Academy of Child and Adolescent Psychiatry 1998;37(11):1225-7.
1997: T E Wilens; Thomas J Spencer; J Biederman
Sudden (un)explained death.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(11):1487-8.
1997: Timothy E Wilens; Joseph Biederman; A M Abrantes; Thomas J Spencer
Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(7):941-7.
1997: Timothy E Wilens; Thomas J Spencer; Joseph Biederman; D Schleifer
Case study: nefazodone for juvenile mood disorders.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(4):481-5.
1997: Timothy E Wilens; Joseph Biederman; Thomas J Spencer
Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(1):45-8.
1996: T E Wilens; Joseph Biederman; R J Baldessarini; B Geller; D Schleifer; Thomas J Spencer; B Birmaher; A Goldblatt
Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(11):1491-501.
1996: T E Wilens; Joseph Biederman; A M Abrantes; Thomas J Spencer
A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(11):1485-90.
1996: Thomas J Spencer; Joseph Biederman; M Harding; D O'Donnell; Stephen Faraone; T E Wilens
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(11):1460-9.
1996: T E Wilens; Joseph Biederman; Jefferson Prince; Thomas J Spencer; Stephen Faraone; R Warburton; D Schleifer; M Harding; C Linehan; Daniel Geller
Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
The American journal of psychiatry 1996;153(9):1147-53.
1996: J B Prince; T E Wilens; J Biederman; Thomas J Spencer; Janet Wozniak
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases.
Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(5):599-605.
1995: Joseph Biederman; T Wilens; Eric Mick; Sharon Milberger; Thomas J Spencer; Stephen Faraone
Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity.
The American journal of psychiatry 1995;152(11):1652-8.
1995: T E Wilens; Thomas J Spencer; J Biederman
Are attention-deficit hyperactivity disorder and the psychoactive substance use disorders really related?
Harvard review of psychiatry 1995;3(3):160-2.
1995: T E Wilens; Joseph Biederman; Thomas J Spencer; Jefferson Prince
Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review.
Journal of clinical psychopharmacology 1995;15(4):270-9.
1995: T E Wilens; J B Prince; J Biederman; Thomas J Spencer; R J Frances
Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults.
Psychiatric services (Washington, D.C.) 1995;46(8):761-3, 765.
1995: T E Wilens; J Biederman; Thomas J Spencer
Venlafaxine for adult ADHD.
The American journal of psychiatry 1995;152(7):1099-100.
1995: T E Wilens; Joseph Biederman; K Kiely; E Bredin; Thomas J Spencer
Pilot study of behavioral and emotional disturbances in the high-risk children of parents with opioid dependence.
Journal of the American Academy of Child and Adolescent Psychiatry 1995;34(6):779-85.
1995: T E Wilens; Joseph Biederman; Eric Mick; Thomas J Spencer
A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder.
The Journal of nervous and mental disease 1995;183(1):48-50.
1994: T E Wilens; J Biederman; Thomas J Spencer; R J Frances
Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders.
Hospital & community psychiatry 1994;45(5):421-3, 435.